Literature DB >> 25107448

Advanced heart block and unresponsiveness after regadenoson administration during myocardial SPECT study.

Vikram Agarwal1, E Gordon DePuey2.   

Abstract

Entities:  

Keywords:  Heart block; Regadenoson; SPECT study

Mesh：

Substances：

Year:  2014        PMID： 25107448     DOI： 10.1016/j.ijcard.2014.07.058

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers.

Authors:  Mridula Rai; Alan W Ahlberg; Julianna Marwell; Waseem Chaudhary; John A Savino; Eric L Alter; Milena J Henzlova; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2016-02-22       Impact factor: 5.952

2.  Regadenoson-induced complete heart block and asystole: A real possibility nuclear laboratories should be aware of.

Authors:  Faraz Kureshi; Mouin S Abdallah; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2016-12-20       Impact factor: 5.952

3.  Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2014-10       Impact factor: 5.952

4.  Regadenoson and seizures: a real clinical concern.

Authors:  Vikram Agarwal; E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

5.  Adverse effects associated with regadenoson myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

6.  Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

Authors:  Efstathia Andrikopoulou; Charity J Morgan; Lizbeth Brice; Navkaranbir S Bajaj; Harish Doppalapudi; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.